Cartalax
Cartalax is a short synthetic tripeptide from the same Khavinson bioregulator family as Epitalon, proposed to activate cartilage matrix gene expression — though its evidence base is considerably thinner than Epitalon's. Not currently stocked by KYIN Peptides, but available to order.
What Is Cartalax?
Cartalax is a synthetic tripeptide (Ala-Glu-Asp) developed within the same Khavinson bioregulator lineage as Epitalon. Bioregulator peptides in this family are proposed to work by binding chromatin and influencing gene transcription in specific tissue types, rather than acting as classic receptor agonists. For Cartalax, the proposed target tissue is cartilage: it is theorized to bind chromatin in chondrocytes (cartilage-forming cells) and activate transcription of cartilage matrix genes, including type II collagen, aggrecan, and link protein.
How the Evidence Compares to Epitalon
Cartalax shares its origin story with Epitalon — both emerged from Vladimir Khavinson's peptide bioregulator research — but the two compounds are not equally well studied. Epitalon has a multi-year human cohort study behind it (see our Epitalon discovery history), while Cartalax's evidence base is considerably thinner. The handful of PubMed-indexed papers referencing Cartalax do not measure a cartilage endpoint directly, and the chondrocyte-proliferation finding most often cited in its favor comes from a single, unreplicated Russian-language animal experiment outside PubMed. See our Longevity & Cellular Health research overview for how Cartalax fits alongside KYIN's stocked longevity-focused peptides.
Availability
Cartalax is not part of KYIN Peptides' standard catalogue, but it is available to order — contact us directly and we'll source it for you.
Cartalax questions
What is Cartalax?
Cartalax is a synthetic tripeptide (Ala-Glu-Asp) from the same Khavinson bioregulator lineage as Epitalon, proposed to bind chromatin in chondrocytes and activate transcription of cartilage matrix genes — type II collagen, aggrecan, and link protein.
How strong is the evidence behind Cartalax specifically?
Weaker than most compounds referenced on this site. The chondrocyte-proliferation finding most often cited for Cartalax comes from unreplicated Russian-language literature outside PubMed, and no PubMed-indexed paper mentioning Cartalax has measured a cartilage-specific endpoint.
Is Cartalax related to Epitalon?
Yes — both come from the same Khavinson bioregulator family of short synthetic peptides, but they target different tissues. Epitalon is studied for telomerase activity and pineal gland function, while Cartalax is studied specifically for cartilage matrix gene activation in chondrocytes.
Does KYIN Peptides sell Cartalax?
Not as part of our standard catalogue, but yes — it's available to order. Contact us directly and we'll source it for you.
Interested in sourcing Cartalax?
Contact us and we'll help you source it, or browse our stocked longevity-focused peptides.